Research Articles
HIV Drug Resistance in the Era of Modern Antiretroviral Therapy
Exploring the declining trends in HIV drug resistance and the scientific advances driving this positive change in modern antiretroviral therapy.
A New Era for HIV Treatment: How Two-Drug Regimens Are Transforming Care in Africa
Exploring the evidence behind two-drug HIV regimens in Africa, their advantages, clinical trial results, and future implications for HIV care across the continent.
Beyond the Virus: Understanding and Preventing Heart Disease in People Living with HIV
Exploring the connection between HIV and coronary artery disease, including risk factors, mechanisms, and prevention strategies based on global systematic review.
CROI 2025: Mapping HIV's Hiding Spots and Charting a Path to a Cure
Key findings from CROI 2025 on HIV reservoir mapping, capsid research, and innovative cure strategies.
The Viral Clones That Outsmart Treatment: The Mystery of Persistent HIV
Discover how clonal viral lineages create persistent HIV viremia despite intensive antiviral therapy and the latest research breakthroughs.
The Hidden Battle: How HIV Weakens Cervical Defenses Against Cancer
Exploring how HIV infection affects neutrophil function in the cervix, increasing vulnerability to cervical cancer in HIV-positive women.
The Unexpected Link: How an HIV Drug's Level in the Body Influences Weight Gain
New research reveals how efavirenz concentration affects weight gain in HIV patients. Discover the science behind this surprising connection.
The First Shot in the War: How the Choice of HIV Drugs Shapes the Battle Inside Your Body
Discover how different antiretroviral regimens affect viral suppression and immune activation during early HIV treatment.
Unlocking HIV's Defenses: How a Tiny Mutation Helps the Virus Outsmart Modern Medicine
Discover how a single amino acid mutation at position 64 in HIV's gp41 protein enables the virus to resist fusion inhibitor drugs and what this means for future treatments.
A Shot of Freedom: The Five-Year HIV Treatment Breakthrough
Learn about the groundbreaking LATTE-2 Week 256 results showing long-acting injectable HIV therapy maintains viral suppression for nearly five years.